Intensive Care Unit, Royal Cornwall Hospital NHS Trust, Truro, UK.
Anaesthesia. 2011 Feb;66(2):92-6. doi: 10.1111/j.1365-2044.2010.06603.x.
We conducted two telephone surveys of all United Kingdom adult intensive care units in 2007/8 and 2010 to assess practice with regard to intensive insulin therapy for glycaemic control in critically ill patients, and to assess the change in practice following publications in 2008 and 2009 that challenged the evidence for this therapy. Of 243 units that had a written policy for intensive insulin therapy in 2007/8, 232 (96%) still had a policy in 2010. One hundred and six (46%) units had updated their policy in response to new evidence, whereas 126 (54%) stated that it had remained the same. Where intensive care units had changed their policy, we found a significant increase in target limits and a wider target range. Regional variations in practice were also seen. Across seven regions, the percentage of units where the glycaemic control policy had been updated since 2007/8 varied from nil to 78.9%.
我们在 2007/8 年和 2010 年对英国所有成人重症监护病房进行了两次电话调查，以评估重症患者血糖控制的强化胰岛素治疗实践情况，并评估 2008 年和 2009 年发布的质疑该疗法证据的出版物发布后实践的变化。在 2007/8 年有强化胰岛素治疗书面政策的 243 个单位中，232 个（96%）在 2010 年仍有政策。106 个（46%）单位根据新证据更新了其政策，而 126 个（54%）表示政策保持不变。在改变政策的重症监护病房中，我们发现目标限制和目标范围明显扩大。实践中也存在区域差异。在七个地区，自 2007/8 年以来更新血糖控制政策的单位百分比从 0 到 78.9%不等。
